Juno Therapeutics Technical Analysis

Juno Therapeutics Inc -- USA Stock  

USD 44.68  0.51  1.15%

Juno Therapeutics Inc retains Market Risk Adjusted Performance of 1.0 and Risk Adjusted Performance of (0.081537). Juno Therapeutics technical analysis makes it possible for you to employ historical prices and volume momentum with intention to determine a pattern that calculates the direction of the corporation future prices. In other words you can use this information to find out if the corporation will indeed mirror its model of historical price patterns or the prices will eventually revert. We found nineteen technical drivers for Juno Therapeutics Inc which can be compared to its competitors. Please check out Juno Therapeutics Inc Standard Deviation, Maximum Drawdown as well as the relationship between Maximum Drawdown and Expected Short fall to decide if Juno Therapeutics is priced fairly providing market reflects its last-minute price of 44.68 per share. Given that Juno Therapeutics Inc has Jensen Alpha of (0.7), we strongly advise you confirm Juno Therapeutics Inc regular market performance to make sure the company can sustain itself at future point.
Investment Horizon     30 Days    Login   to change

Juno Therapeutics Inc Trend Analysis

Use this graph to draw trend lines for Juno Therapeutics Inc. You can use it to identify possible trend reversals for Juno Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Juno Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Juno Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Juno Therapeutics Inc applied against its price change over selected period. The best fit line has a slop of 1.02 % which may suggest that Juno Therapeutics Inc market price will keep on failing further. It has 34 observation points and a regression sum of squares at 850.27, which is the sum of squared deviations for the predicted Juno Therapeutics price change compared to its average price change.

Did you try this?

Run Crypto Portfolio Optimizer Now

Crypto Portfolio Optimizer

Optimize portfolio of digital coins and token across multiple currency and exchanges
Hide  View All  NextLaunch Crypto Portfolio Optimizer
Juno Therapeutics Inc is currently regarded as number one stock in mean deviation category among related companies. It is currently under evaluation in standard deviation category among related companies creating about  1.26  of Standard Deviation per Mean Deviation. The ratio of Standard Deviation to Mean Deviation for Juno Therapeutics Inc is roughly  1.26